Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma

This is an open-label, prospective, randomized, Phase III, international multicenter clinical study to compare radiotherapy plus nimotuzumab versus radiotherapy alone in platinum-ineligible patients with locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC),

NCT Number	NCT07333274
Lead Sponsor	Shandong Cancer Hospital and Institute
Conditions	Head & Neck Squamous Cell Carcinoma, Head & Neck Cancer
Enrollment	335 participants
Start Date	2026-01-05
Primary Completion	2028-01-05 (estimated)
Study Completion	2030-01-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-12